Literature DB >> 18957485

Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature.

B Hervier1, C Pagnoux, C Agard, J Haroche, Z Amoura, L Guillevin, M A Hamidou.   

Abstract

OBJECTIVE: To describe the clinical presentation of the association between pulmonary fibrosis (PF) and systemic vasculitis related to antineutrophil cytoplasmic antibodies (ANCA-V).
METHODS: 12 patients (three female, mean age 70.7 years) with ANCA-V associated with "idiopathic" PF were studied retrospectively.
RESULTS: ANCA-V and PF were diagnosed simultaneously in eight cases; PF occurred earlier in three cases and during ANCA-V follow-up in one. No patient had intra-alveolar haemorrhage (IAH). ANCA were myeloperoxidase (MPO)-ANCA in all cases. Seven patients had blood eosinophilia at diagnosis. Two patients died during ANCA-V induction therapy. The respiratory status of five patients worsened and three of them died from exacerbation of end-stage respiratory failure. The five remaining patients had a stable respiratory status.
CONCLUSION: The association of PF and ANCA-V does not seem to be fortuitous, even though their clinical evolutions are clearly not related. PF was the major cause of death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957485     DOI: 10.1136/ard.2008.096131

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.

Authors:  Misbah Baqir; Eunhee E Yi; Thomas V Colby; Christian W Cox; Jay H Ryu; Ulrich Specks
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

3.  Microscopic polyangiitis associated with pulmonary fibrosis.

Authors:  Marcelo Fernandez Casares; Alejandra Gonzalez; Mariano Fielli; Flavia Caputo; Yanina Bottinelli; Marcelo Zamboni
Journal:  Clin Rheumatol       Date:  2014-05-27       Impact factor: 2.980

4.  Pyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis.

Authors:  O Shields; A Shah; B Mann
Journal:  BMJ Case Rep       Date:  2011-04-15

5.  Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.

Authors:  Hironao Hozumi; Noriyuki Enomoto; Yoshiyuki Oyama; Masato Kono; Tomoyuki Fujisawa; Naoki Inui; Yutaro Nakamura; Takafumi Suda
Journal:  Lung       Date:  2016-02-12       Impact factor: 2.584

Review 6.  Pulmonary vasculitis: clinical presentation, differential diagnosis, and management.

Authors:  Jennifer Ramsey; Mohammed Amari; Stephen P Kantrow
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

7.  Elevated serum levels of two anti-neutrophil cytoplasmic antibodies in a lung cancer patient: A case report.

Authors:  Shinichiro Okauchi; Tomohiro Tamura; Katsunori Kagohashi; Mio Kawaguchi; Hiroaki Satoh
Journal:  Biomed Rep       Date:  2016-09-06

8.  [Pulmonary fibrosis].

Authors:  A Prasse; J U Holle; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

9.  Idiopathic Interstitial Pneumonia as a Possible Cause of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report.

Authors:  Hiroshi Oiwa; Katsuhiro Ooi; Tetsu Oyama; Eiji Sugyama
Journal:  Arch Rheumatol       Date:  2018-01-15       Impact factor: 1.472

10.  Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?

Authors:  Amir Bhanji; Mahzuz Karim
Journal:  NDT Plus       Date:  2010-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.